Background: Neuroimmune interactions play a vital role in many of the most common pain conditions, such as arthritis. There have been many attempts to derive clinically predictive information from an individual's inflammatory response in order to gauge subsequent pain perception. Objectives: Here, we wanted to test whether this effort could be enhanced and complemented by the use of a model system which takes into account the function of not just circulating, but also tissue-resident immune cells: ultraviolet B (UVB) irradiation of the skin. Methods: We conducted psychophysical and transcriptional analysis of hyperalgesia arising as a result of UVB-induced inflammation in patients before total knee arthroplasty (TKA, n = 23). Levels of acute postoperative pain were assessed and correlated with preoperative data. Results: Cytokine and chemokine responses after UVB irradiation were found to be inversely correlated with the level of pain experienced after surgery (Spearman's q = À0.498). Conclusion: It may be possible to use this simple model to study and predict the nature of neuro-immune responses at more remote, clinically relevant sites. Significance: A simple model of UVB inflammation in the skin might predict the degree of a patient's neuro-immune response and the extent of their postoperative pain after total knee arthroplasty.
Introduction
Neuroimmune interactions are a vital element of many of the most common pain conditions, such as arthritis (Pongratz and Straub, 2013) . A wealth of evidence suggests that injury and disease causes the release of pro-inflammatory mediators from immune or resident cells which then sensitize peripheral neurons, sometimes over long periods of time (McMahon et al., 2015) .
In the clinic, there have been many attempts to capture the precise nature of these interactions on a patient by patient basis, with the intention to predict treatment outcomes. The identification of biomarkers, in particular, has made major strides in just a few years, especially in the field of osteoarthritis (Lafeber and van Spil, 2013; Bay-Jensen et al., 2016) . However, their adoption into the clinic or for pharmaceutical trials remains difficult (Bay-Jensen et al., 2016) . There are many reasons for the slow process, but one issue relates to the inaccessibility of affected tissues. It is often not feasible to obtain the cartilage or deep muscle fibres that are actually innervated by nociceptors. Instead, most studies rely on the analysis of circulating mediators in blood, synovial fluid or urine, which does not provide any information about the state of local immune cells which can play a crucial part peripheral sensitization (Calvo et al., 2012) . Here, we propose the use of a novel paradigm: the study of skin inflammation as an easily accessible predictive model system for distant tissue resident neuroimmune interactions.
Short wave, ultraviolet B (UVB) irradiation of the skin, otherwise known as sunburn, has been developed as a preclinical model of inflammatory pain. It can be used to induce a textbook peripheral sensitization of nociceptors (Lopes and McMahon, 2016) and is one of the few models in the literature that translates well between animals and humans, on a behavioural as well as molecular level (Dawes et al., 2011 (Dawes et al., , 2014 . We therefore suggest that UVB inflammation could be used to capture individual differences in the cross-talk between neurons and immune cells that might then also apply to diseaserelevant tissues. We hypothesized that gene expression changes resulting from preoperative UVB-induced skin inflammation may correlate with acute postoperative pain.
Here, we report on a proof of principle experiment with a prospective study cohort of patients scheduled for total knee arthroplasty (TKA). More than 700,000 US citizens undergo TKA every year for the treatment of arthritic conditions, be they degenerative due to advanced age or traumatic in origin (http://www.cdc.gov/nchs/fastats/inpatient-surgery. htm). Despite complex multimodal analgesic regimens, more than half of patients still report at least moderate pain one month after the intervention (Andersen et al., 2009) , and up to 20% develop a chronic pain condition, especially those whose acute pain responses were severe (Beswick et al., 2012; Lewis et al., 2015) .
We induced skin inflammation via UVB irradiation before patients underwent TKA and obtained both psychophysical and transcriptional readouts relating to their level of hyperalgesia. Cytokine and chemokine responses after UVB irradiation were found to be inversely correlated with acute pain experienced after knee replacement surgery. Our results demonstrate that it is possible to use sunburn-induced inflammation as a model to study and predict the nature and extent of neuro-immune interactions and pain at more remote, clinically relevant sites.
Methods

Study design and patients
The study was approved by the regional ethics committee, Capital Region of Denmark, and the Danish Data Protection Agency. Oral and written informed consent was obtained from all patients before participation in this single-centre, prospective, observational cohort study.
Patients scheduled to undergo elective, unilateral, primary TKA were recruited from the department of Orthopedic Surgery, Copenhagen University Hospital, Hvidovre, Denmark between March 4th, 2013 and May 5th, 2014 at a prescheduled (study independent) hospital visit for clinical examination preceding admission for surgery (last patient operated on May 14, 2014). Exclusion criteria were age below 18 years, unfamiliarity with the Danish language, insufficient mental capacity to provide informed consent and to understand study procedures, skin types other than Fitzpatrick Scale 1 or 2 (Astner and Anderson, 2004) , fertile women (menstruation within 2 years), use of opioids or of any kind and immune modulating drugs (systemic glucocorticoids, TNF-alpha-inhibitors, etc.) up to 4 weeks prior to surgery, current anticoagulant medication (Warfarin), dermatological diseases such as psoriasis and eczema, infection or previous operation at the site of UVB irradiation and skin biopsy, history of allergic reaction or hypersensitivity to local anaesthetic, diseases affecting central or peripheral nerve function, history of or treatment for bipolar affective disorder, anxiety or fibromyalgia that may affect postoperative pain perception or behavior, and history of alcohol or drugs abuse.
Preoperative visits 1: Patient interview and UVB irradiation
The first preoperative visit took place at Copenhagen University Hospital, Hvidovre, 1-2 weeks before surgery. We registered the patients' demographics, daily analgesic use and average preoperative knee pain at rest and upon ambulation.
Next, UVB irradiation was performed on the anterior thigh at the transition between the proximal and middle third on the side opposite to planned surgery. Any hair was gently removed with scissors to avoid flushing. The patient's skin pigment factor was assessed with four repeat measurements with a calibrated chromolight. A photometer was used to assess the strength of the UVB lamp (IL1400A with SEL240/UVB-1/TD filter, ABLE Instruments and Controls). The average pigment factor and UVB light strength were then used to calculate a skin-type specific dose (exposure time) of the subsequent UVB irradiation. The lamp used generated a UVB wavelength of 315 nm-280 nm and was placed at a set distance from the skin. Five small patches (<1.5 cm 2 ) were exposed to varying levels of irradiation corresponding to an estimated 0.75, 1.0, 1.5, 2.0 and 3.0 minimal erythema dose (MED). The rest of the leg and lower body was covered in thick dark fabric and both patient and investigator wore goggles. Testing was performed with the patient in supine position in a closed and quiet room.
At the end of the session, patients were instructed not to take any NSAIDs, opioids or antihistamines the next 48 h (between visit 1 and 2), and not to take acetaminophen or consume caffeine 6 h before visit 2.
The UVB irradiation protocol was set up in a collaborators meeting in Copenhagen preceding the study. Also, a small unpublished pilot study (N = 6) was conducted to standardize all testing procedures before initiation of the study.
Preoperative visit 2: Somatosensory testing and skin punch biopsies
The second preoperative visit also took place at Copenhagen University Hospital, Hvidovre, 48 h after visit 1. First, it was confirmed that intake of anti-inflammatory drugs, opioids, antihistamines, acetaminophen and caffeine containing drinks had been restricted.
The UVB irradiated skin patches were then evaluated under standardized light conditions. The 1 MED skin patch was defined as the lowest one of the three patches (estimated 0.75, 1.0, 1.5) characterized with clear redness and well-demarcated edges (Bishop et al., 2009) . The 2 MED patch was then chosen as the patch irradiated twice as much as the 1 MED patch. The 2 MED patch, together with a non-irradiated control skin area localized 5 cm distally to the lowest situated of the originally UVB irradiated areas, were the areas used for somatosensory testing and skin biopsy. If patients based on the evaluation were not sufficiently UVB irradiated, that is if none of the estimated 0.75, 1.0 and 1.5 MED skin patches fulfilled the definition of being actually 1 MED, the patient was excluded. This was done to ensure evaluation of biological variability in inflammatory response to standardized, skin-type specific UVB-exposure rather than to differences in the dose of UVB-exposure. In all patients, a digital photograph of the UVB irradiated skin patches was taken by the clinician for later confirmatory evaluation by an independent scientist from the UK team. Those photographs were then scored once more and patients excluded from transcriptional analysis if UVB-irradiation was considered <2 MED.
Somatosensory thresholds of patients were measured in the 2 MED patches as well as in a control skin area using the up-down method with calibrated von Frey monofilaments (Linton Instrumentation). Skin punch biopsies (3 mm 2 ) were taken aseptically (Lauria et al., 2010) both from the 2 MED patches and the control skin area using 1% lidocaine as an anaesthetic. They were snap frozen and shipped to the UK for RNA extraction.
Anaesthesia, surgery and analgesia
Surgical procedure, technique, anaesthesia, and analgesia were standardized for all patients. Included patients were scheduled for surgery as number 1 or 2 each day. Surgery was performed under lumbar spinal anaesthesia with hyperbaric bupivacaine 0.5% and optional supplemental propofol (1-5 mg/kg/h). TKA was performed using a standard medial parapatellar approach and a femoral tourniquet (100 mmHg above systolic blood pressure) inflated just prior to incision and deflated after insertion of the prosthesis and closure of the skin, and without application of surgical drains. Local infiltration analgesia (LIA) was performed intraoperatively with 150 mL ropivacaine 0.2% with epinephrine (10 lg/mL; Andersen and Kehlet, 2014) . By the end of surgery, an elastic bandage was applied from toes to mid-thigh.
A basic analgesic regime was used consisting of oral slow release acetaminophen and celecoxib. Preoperatively, acetaminophen 2 g and celecoxib 400 mg were administered; thereafter acetaminophen 2 g and celecoxib 200 mg were administered regularly at 8:00 AM and 10:00 PM. Rescue analgesics (administered on demand as required if VAS >50 mm at rest) consisted of oral morphine 10 mg (patients above 70 years) and 20 mg (patients below 70 years). Patients followed a well-defined, fast-track rehabilitation regime (Husted et al., 2011) and were discharged to their homes according to routine functional discharge criteria.
Postoperative assessments/outcome meassures
Levels of pain were assessed at regular intervals after surgery (6, 24, 28, 32 and 48 h) using the 100 mm visual analogue scale (VAS; 0 = no pain and 100 = worst pain imaginable; subjective rating by patients). All scores were summed to create four separate variables: pain at rest (in supine position), pain while flexing the knee, pain while flexing the hip (straightening the knee) and pain while walking a 5 m stretch.
If patients were unable to walk during given assessment due to the high level of pain, a VASvalue of 100 was registered. In a few cases, patients were unable to walk due to dizziness upon standing (at 6 h), then the next measurable score was carried back. A compound pain score was created by summing up the different pain measures into one.
Compliance with the basic analgesic regime and use of oral morphine from 0 to 48 h was registered. In the few cases where other opioids (ketobemidone, oxycodone and intravenous morphine) were used due to resistant pain, these were converted into per oral morphine equivalents. These scores were used to generate a fifth outcome variable of cumulative morphine use. Trial participants, care providers and outcome assessors were all blinded to the result of the preoperative somatosensory testing. Sample quality was assessed on a RNA 6000 Nano Chip (Agilent) and reverse transcription was performed using the enzyme Transcriptor reverse transcriptase (cat no 3531287001) from Roche, Welwyn Garden City, UK. Quantitative real time polymerase chain reaction (qRT-PCR) was carried out on a 7900HT Fast Real-Time PCR system (Applied Biosystems, Foster City, CA, USA) using Taqman 384 well microfluidic cards. RNA expression levels were determined using the fold change (FC; ddCT) method, whereby raw cycling thresholds were normalized to the mean of four housekeeping genes (18S, ACTB, GAPDH, HPRT1), followed by further normalization of each UVB sample to its paired control sample.
RNA extraction and qRT-PCR
Statistical analysis
Of the 96 genes on the Taqman array card, four were housekeepers. Genes with cycling thresholds of 35 or above under both UVB and control conditions in more than 15 patients were deemed to be absent from skin. For the remaining 64 genes, one-sample, two tailed t-tests were used to identify those that were significantly dysregulated after UVB treatment. Benjamini-Hochberg (BH) multiple comparison correction was applied, and genes considered significant at adjusted p < 0.05.
Since not all genes and variables were normally distributed, Spearman's rank correlations were used for the majority of comparisons in this paper, apart from the multiple regression analysis.
The six genes identified to be most correlated with pain while walking were aggregated into a compound score ('inflammatory index') by summing up their FC (ddCT) values.
All preoperative variable, including the inflammatory index, were tested for correlation with our outcome measures (postoperative pain while walking, compound postoperative pain and morphine use).
A multiple linear regression analysis was carried out using the forward method, with the compound pain score used as the dependent variable and preoperative pain at rest and the inflammatory index used as independent (explanatory) variables. Both independent variables were in linear relationship with the dependent variable, which was normally distributed. The two independent variables did not In one patient, celecoxib was stopped the 1st postoperative evening due to hemathemesis (disappearing after pantoprazol, not requiring blood transfusion); c hyperbaric bupivacaine 7.5-10 mg (AE sedation with propofol).
display any multi-collinearity: Pearson's r = 0.124; tolerance = 0.985; VIF = 1.016, condition index = 6.04. The noise between variables appeared to be equivalent as assessed by scatter plots of residuals versus predicted values.
Results
Characteristics of patients that underwent TKA surgery
A total of 243 patients were assessed for eligibility and based on a set of criteria outlined in the materials and methods, 44 patients were recruited. For reasons outlined in Fig. 1 , 23 patients were included in the final analysis. Baseline patient characteristics and preoperative pain data are presented in Table 1 . Sixteen were male, seven were female and their mean age was 62.
Postoperative pain
Pain-related outcome data are presented in Table 2 . As expected, all outcome variables were strongly and significantly correlated with each other: pain at rest was related to pain upon hip flexing (q = 0.67), knee flexing (q = 0.77) and walking (q = 0.67), as well as morphine use (q = 0.60). Compliance with the basic analgesic regime was complete in 22 of the 23 patients (Table 2) .
Gene expression changes associated with UVB-induced skin inflammation
Preoperatively, small patches of patient skin were irradiated with UVB in a carefully controlled setting, accounting for pigmentation and UVB light strength (see Materials and Methods for more details). Skin biopsies were taken from the treated area and an adjacent unaffected patch of skin for RNA extraction and high-throughput qRT-PCR analysis. Ninety-two immune-related genes were measured, 64 of which were found to be expressed in the skin. Of those, 26 were significantly upregulated and 13 significantly down-regulated by UVB-induced inflammation ( Fig. 2A) . The pattern of change faithfully mirrored that identified in healthy volunteers by one of our previous studies (Dawes et al., 2011; Fig. 2B) . genes that were significantly up-(in purple) or down-regulated (in turquoise) in UVB-compared to non-irradiated control skin (one-samples, twotailed t-tests, (BH adj. p < 0.05). Each column represents an individual patient. FC = fold change. (B) Gene expression changes correlated well with those previously found after UVB irradiation. Ranked FCs obtained in our current qRT-PCR analysis were plotted against those obtained in one of our previous studies. Spearman's q = 0.91. Genes highlighted in grey were only significantly dysregulated in the current cohort, all others were significantly dysregulated in both.
UVB-upregulated genes negatively correlated with postoperative pain
Next, we sought to test whether any of the 26 genes induced by inflammation could serve as markers for surgery-associated acute postoperative inflammation and pain. Indeed, six of the genes were found to be significantly negatively correlated with our most clinically relevant outcome measure of postoperative pain while walking (Table 3 , Supporting Information Fig. S1 ): IL20, CCL20, CCL18, CXCL5, CXCL10 and CXCL17. A compound score was created by summing the fold change (FC) values for these six genes, which will be referred to as the 'inflammatory index'. The inflammatory index, as well as CXCL5, CXCL10 and CXCL17 were also correlated with postoperative pain scores as a whole, which took into account pain upon walking, as well as at rest, upon hip flexing and upon knee flexing (Fig. 3) . We also investigated the relationship between postoperative pain levels, the inflammatory index and skin sensitivity after UVB inflammation (Supporting Information Fig. S2 ). No clear connection emerged when examining these three measures in tandem.
Preoperative pain and UVB-induced gene expression predicted extent of postoperative pain
Of all the preoperative variables that were assessed for this study (see Table 1 ), only preoperative pain at rest as well as the inflammatory index significantly correlated with the level of acute postoperative pain (Spearman's q = 0.504 and À0.498, respectively, Fig. 4) . A multiple regression analysis revealed both factors to be significant predictors, accounting for more than half of the variance (F(2,20) = 14.108, p < 0.001, adj. R 2 = 0.544). Pain at rest was the more important variable in this equation, predicting 40% of the variance on its own (adj. R 2 = 0.404, p = 0.001), while the inflammatory index added a further 14% (p = 0.013).
Postoperative morphine use was significantly correlated with preoperative pain levels at rest, as well as with skin hypersensitivity after UVB inflammation (q = 0.502, p = 0.015 and q = 0.482, p = 0.02, respectively).
Discussion and conclusions
This study was conceived as a proof of principle experiment to test whether UVB-induced skin inflammation could be used to model individual differences in neuro-immune interactions that might help predict pain at more remote, clinically relevant sites.
Indeed, we found that gene expression changes resulting from UVB inflammation could be used to predict the level of postoperative pain experienced by patients after knee replacement surgery. They were particularly well correlated with pain experienced while walking and together with preoperative pain levels at rest predicted more than 50% of the variance of our compound postoperative pain outcome.
One surprising result was that in contrast to preoperative pain levels, our genetic inflammatory index was negatively correlated with pain after TKA. It thus appears that the stronger the patients' immune response to UVB irradiation -at least as measured by transcription, the less likely they were to experience acute pain after surgery. One explanation is that a more vigorous inflammatory response More than half of the genes were found to be negatively correlated, six significantly so at p < 0.05 (in bold): IL20, CCL18, CCL20, CXCL5, CXCL10 and CXCL17. We generated a compound measure (the 'inflammatory index') for further downstream analysis, by collapsing the significantly correlated genes using the sum of their mean ddCT values. * p < 0.05, ** < p 0.01
can induce more vigorous tissue repair -a possibility which has been put forward previously in the context of knee injury (Watt et al., 2016) . Watt et al. found that patients with the highest levels of synovial IL6 and inflammation after knee surgery recovered just as fast as their more weakly responding counterparts. The authors attributed these faster recovery times to either one of two factors: patients with higher initial inflammation and pain might simply perceive a bigger drop in pain intensity given their different starting points; or there could be a real physiological process whereby a stronger immune response initiates better healing. Our data would support the latter explanation. One could for instance imagine that individual differences in the number of wound healing macrophages might result in the kind of observations made in this and Watt et al.'s study. Our analyses also highlighted the importance of three mediators that were most strongly correlated with subsequent pain perception: CXCL10, CXCL17 and CXCL5. CXCL10 has been implicated in allergic contact dermatitis (Kamsteeg et al., 2010) , though primarily in the generation of itch rather than pain (Qu et al., 2015) . CXCL17 is thought to be a macrophage chemoattractant (Burkhardt et al., 2014) with an as yet unexplored role in pain perception. But it is CXCL5 which may be the most promising single molecule predictor of neuro-immune responses at other sites. The study of its expression levels could potentially inform on both an individual's 'proinflammatory tone' and wound healing potential. In many contexts, CXCL5 helps activate pro-inflammatory processes: we previously identified CXCL5 to be one of the most upregulated genes after UVB irradiation in skin (Dawes et al., 2011) ; its administration in animal models can cause the same kind of mechanical hypersensitivity associated with UVB inflammation itself; and finally, it is has been found to be highly upregulated in a mouse model of arthritis (Takahashi et al., 2008) . Conversely, CXCL5 can also aid tissue protection and repair in a variety of contexts. For instance, in atherosclerosis, it has been shown that CXCL5 is capable of targeting alternatively activated M2 macrophages (Rousselle et al., 2013) , while in the skin it helps recruit mesenchymal stem cells contributing to cutaneous wound healing (Lau et al., 2009 ).
When interpreting our results, it is important to keep in mind certain limitations inherent in our study design. First, we did not collect blood or synovial fluid for analysis of circulating biomarkers, as Figure 4 Pain at rest and the inflammatory index were the only two preoperative variables that correlated with postoperative pain scores. Scatter plots and Spearman's correlations between the different parameters measured as part of this study: gender, smoking, age, body mass index, regular preoperative use of pain relieving medication, skin hypersensitivity after ultraviolet B, preoperative pain at rest and while walking, genetic skin inflammatory index. Significantly correlated variables are plotted in turquoise.
we aimed to evaluate neuro-immune responses at a remote site. Second, we did not conduct long-term follow-up, but focused on acute postoperative pain. Third, our rigorous inclusion and exclusion criteria meant we were left with a limited sample size and the consequent risk of missing any smaller effects. On the other hand, our protocol was kept highly standardized, controlling for intraoperative and postoperative factors (anaesthesia, surgery and analgesia), and we are confident we ensured an evaluation of biologic variability (response to UVB), not difference in exposure. Pain outcomes were also assessed in a standardized manner by investigators blinded to preoperative measurements.
In conclusion, we carried out a prospective study designed to examine a link between a patient's immune response and their pain after knee replacement surgery. Inter-individual variation in postoperative pain responses is known to be pronounced and have complex origins. Both psychological and somatic factors have been associated with increased risk of postoperative pain, such as pain catastrophizing (Edwards et al., 2009; Riddle et al., 2010; Khan et al., 2011; Sullivan et al., 2011; Lunn et al., 2013) , anxiety (Brander et al., 2003; Lunn et al., 2013) , depression (Brander et al., 2003; Sullivan et al., 2009; Rakel et al., 2012) , younger age (Rakel et al., 2012) , preoperative pain (Brander et al., 2003; Sullivan et al., 2009; Rakel et al., 2012; Lunn et al., 2013) , chronic pain conditions with central sensitization such as fibromyalgia (Brummett et al., 2013) and preoperative opioid usage (Aasvang et al., 2016) . However, their predictive strength has not been striking, and little is known about their underlying mechanisms. Recently, patient-specific immune cell states evaluated by mass cytometry have been demonstrated to be strongly correlated with postoperative outcome measures of recovery including functional impairment, postoperative pain and fatigue in patients undergoing hip replacement (Gaudilliere et al., 2014; Fragiadakis et al., 2015) . The authors reported convergent findings with blood samples obtained shortly after (Gaudilliere et al., 2014) as well as prior to surgery (Fragiadakis et al., 2015) .
Despite weaker correlations, our study also suggests a crucial role for neuro-immune interactions in the emergence of postoperative pain, this time of the knee. We do not believe that the inflammatory index we calculated here explains enough of the variance to make it a suitable primary clinical tool for the prognosis of acute postoperative pain. However, it may well serve as a better predictor of other, more chronic pain conditions, such as persistent post-surgical pain or postherpetic neuralgia following shingles infection. The latter might be a particularly interesting subject of future study, since it is a condition that directly involves the skin -the site we used to model our patients' neuroimmune interactions.
The existence of a link between preoperative inflammatory characteristics and postoperative clinical pain certainly supports our initial exploratory hypothesis, namely that an individual's baseline immune response might be implicated in his/her nociceptive processing. If similar evidence continues to mount, it may bring us one step closer to a better understanding of individualized risk factors and the holy grail of predictive diagnostic tests and personalized analgesic treatment protocols.
